drugset / Trial / NCT01771406

CPAP and Nebivolol in Hypertensive Obstructive Sleep Apnea (OSA) Patients.

NCT01771406

Phase 4 Unknown 36 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedCrossoverOpen-labelTreatment

Summary

The aim of this study is to examine how effective CPAP treatment and treatment with nebivolol are respectively on reducing blood pressure and on endothelial dysfunction in patients suffering from obstructive sleep apnea and hypertension.

Timeline

Start
2013-02
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Nebivolol Other / unclassified 5 mg